CN103495025A - Traditional Chinese medicine preparation for treating pulmonary fibrosis - Google Patents

Traditional Chinese medicine preparation for treating pulmonary fibrosis Download PDF

Info

Publication number
CN103495025A
CN103495025A CN201310466775.3A CN201310466775A CN103495025A CN 103495025 A CN103495025 A CN 103495025A CN 201310466775 A CN201310466775 A CN 201310466775A CN 103495025 A CN103495025 A CN 103495025A
Authority
CN
China
Prior art keywords
pulmonary fibrosis
chinese medicine
traditional chinese
treatment
herb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310466775.3A
Other languages
Chinese (zh)
Inventor
张洪胜
于萍萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310466775.3A priority Critical patent/CN103495025A/en
Publication of CN103495025A publication Critical patent/CN103495025A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine preparation for treating pulmonary fibrosis. The preparation is characterized by consisting of traditional Chinese medicinal raw materials by weight as follows: 6-9g of radix glehniae, 6-9g of polygonatum kingianum, 6-9g of dioscorea nipponica makino, 6-9g of Platycodon grandiflorum, 10-15g of manchurian lilac barks, 6-9g of wingedtooth laggera herb, 9-12g of sauropi folium, 10-12g of perfoliote knotweed herb, 10-15g of Rabdosia rubescens, 6-8g of Japanese inula herb, 6-8g of lumbricus and 6-9g of liquorice. The Chinese traditional medicine treatment on the disease has the beneficial effects of tonifying qi and yin, eliminating phlegm, dredging channels, dissipating phlegm to remove asthma and supporting the healthy energy, is good in curative effect, short in course of treatment, high in cure rate and low in cost and hardly causes toxic or side effects.

Description

A kind of Chinese medicine preparation for the treatment of pulmonary fibrosis
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of pulmonary fibrosis.
Background technology
As everyone knows, pulmonary fibrosis, the lungs stroma consists of collagen protein, elastoidin and albumen carbohydrate, when fibroblast is subject to chemical or physical property injury, can secretes the repairing that collagen protein carries out interstitial tissue of lung, and then cause the lungs fibrosis.Pulmonary fibrosis is many in the morbidity of 40-50 year.Dyspnea is the common sympton of pulmonary fibrosis.During slight pulmonary fibrosis, when dyspnea is all in aggravating activities, occur, therefore usually out in the cold or mistaken diagnosis is other diseases.When pulmonary fibrosis makes progress, dyspnea also occurs when tranquillization, carrying out property dyspnea can appear in serious pulmonary fibrosis patients.Other symptoms have dry cough, weak.50% patient has drumstick finger and cyanosis, at base of lung section audible and the tiny race of air-breathing art, splits sound.At present treatment hormones, the symptomatic treatments of adopting more, the traditional Chinese medical science by cardinal symptom " cough ", " breathing heavily ", " expectorant " combination expect four diagnostic methods determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.Can effectively treat pulmonary fibrosis.
Summary of the invention
The beneficial effect of Chinese traditional treatment primary disease is: supplementing QI and nourishing YIN, the dredging collateral that eliminates the phlegm, resolving phlegm and relieving asthma, strengthening the body resistance.Clinical often according to different pattern of syndrome determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.
The objective of the invention is in order to solve above-mentioned technical deficiency, provide good effect, short treating period, cure rate high, a kind of Chinese medicine preparation for the treatment of pulmonary fibrosis that cost is low and toxic and side effects is few.
For achieving the above object, a kind of Chinese medicine preparation for the treatment of pulmonary fibrosis is characterized in that the crude drug of Chinese medicine consists of: Radix Glehniae 6~9g, Rhizoma Polygonati 6~9g, Rhizoma Dioscoreae Nipponicae 6~9g, Radix Platycodonis 6~9g, Cortex Syingae Amurensis 10~15g, Wingedtooth Laggera Herb 6~9g, imperial Jue leaf 9~12g, Herba Polygoni cymosi 10~12g, Rabdosia rubescens 10~15g, Herba Inulae 6~8g, Pheretima 6~8g, Radix Glycyrrhizae 6~9g.
Chinese medicine Radix Glehniae sweet-bitter flavor of the present invention is light, cool in nature.Function cures mainly: nourishing YIN and clearing away lung-heat, expelling phlegm for arresting cough.Control lung-heat type cough, the chronic consumptive disease chronic cough, the moon is hindered dry pharynx, thirsty.The Rhizoma Polygonati sweet in the mouth, property is flat.Return lung, spleen, kidney channel.Function cures mainly: nourishing kidney lung moistening, invigorating the spleen and replenishing QI.For lung-dryness syndrome due to deficiency of YIN, the few expectorant of dry cough, and the chronic cough chronic cough of YIN-deficiency of the lung and kidney; Weakness of the spleen and stomach, both tonifying spleen-yin, strengthening the spleen gas again; Deficiency of kidney essence obtains dizzy, soreness of the waist and knees, early whitening of beard and hair and quenching one's thirst.Radix Platycodonis bitter in the mouth, suffering, property is flat.Return lung meridian.Effect: lung qi dispersing, eliminate the phlegm, sore-throat relieving, evacuation of pus, sharp the five internal organs, fill blood, mend five kinds of over strain, foster the spirit of nobility." not Lu ": sharp the five internal organs the intestines and stomach, the gas of enriching blood, except cold and heat, migratory arthralgia, the warming middle-JIAO rapid digestion of food, treat the laryngopharynx pain.Rhizoma Dioscoreae Nipponicae is warm in nature, sweet in the mouth, hardship.Function cures mainly: relaxing muscles and tendons to promote blood circulation, relieving cough and resolving phlegm, wind-expelling pain-stopping.For traumatic injury, sprain one's back, cough pant, tracheitis, bronchitis ....The Cortex Syingae Amurensis bitter in the mouth, cold nature.Return lung meridian.Function with cure mainly: lung heat clearing away, sputum eliminating, relieving cough and asthma.For the cough with asthma abundant expectoration.Wingedtooth Laggera Herb acrid in the mouth, hardship, cool in nature.Attach to the lung and stomach meridians.Function cures mainly: heat-clearing and toxic substances removing, eliminating phlegm and stopping cough.For anemopyretic cold, laryngopharynx swelling and pain, cough due to lung-heat, acute toothache.Dragon Jue leaf sweet in the mouth, light, property is flat.Attach to the lung and stomach meridians.Function with cure mainly: nourishing the lung to arrest cough, relieving constipation.For the xeropulmonary cough, pharyngalgia aphonia, constipation.Herba Polygoni cymosi bitter in the mouth, acid, cool in nature.Function with cure mainly: heat-clearing and toxic substances removing, inducing diuresis to remove edema, cough-relieving.For laryngopharynx swelling and pain, cough due to lung-heat, children's's pertussis, edema oliguria ....Rabdosia rubescens bitter in the mouth, sweet, cold nature.Return lung, stomach, Liver Channel.Function with cure mainly: heat-clearing and toxic substances removing, promoting blood circulation and stopping pain.For laryngopharynx swelling and pain, abdominal mass abdominal mass mass in the abdomen, snake bite and insect sting.Herba Inulae bitter in the mouth, suffering, salty, warm in nature.Return lung, large intestine channel.Function with cure mainly: sending down the abnormal ascending QI, expectorant, the row water.For affection of exogenous wind-cold, phlegm retention is held knot, cough with asthma abundant expectoration, chest and diaphragm feeling of fullness.Pheretima is cold in nature, salty in the mouth.Heat clearing away arresting convulsion, dredging collateral, relieving asthma, diuresis.Modern study, have thrombolytic and anticoagulant, antiasthmatic effect.The Radix Glycyrrhizae sweet in the mouth, property is flat.Effect and effect: QI invigorating invigorating middle warmer, relieving spasm to stop pain, nourishing the lung to arrest cough, eliminating fire and detoxication, coordinating the actions of various ingredients in a prescription." not Lu ": warming the middle warmer and descending qi, stuffy sensation with restlessness is losed heart, and hinders dirty cough, quench the thirst, qualcomm meridian, sharp vim and vigour, separate hundred poison of drug.Above all medicines match, and by oral administration and externally, treat this disease, bring out the best in each other.
The present invention follows the prescriptions principle of the traditional Chinese medical science, is decocted in water for oral dose.The present invention is through clinical verification: effective percentage is more than 90%, and cure rate is, more than 85%, to have no side effect.
The specific embodiment
Below in conjunction with implementing case, the invention will be further described:
Embodiment 1: a kind of Chinese medicine preparation for the treatment of pulmonary fibrosis is characterized in that by following proportioning weighting raw materials thing: Radix Glehniae 6~9g, Rhizoma Polygonati 6~9g, Rhizoma Dioscoreae Nipponicae 6~9g, Radix Platycodonis 6~9g, Cortex Syingae Amurensis 10~15g, Wingedtooth Laggera Herb 6~9g, imperial Jue leaf 9~12g, Herba Polygoni cymosi 10~12g, Rabdosia rubescens 10~15g, Herba Inulae 6~8g, Pheretima 6~8g, Radix Glycyrrhizae 6~9g.
Embodiment 2: a kind of Chinese medicine preparation for the treatment of pulmonary fibrosis is characterized in that by following proportioning weighting raw materials thing: Radix Glehniae 9g, Rhizoma Polygonati 9g, Rhizoma Dioscoreae Nipponicae 9g, Radix Platycodonis 9g, Cortex Syingae Amurensis 10g, Wingedtooth Laggera Herb 9g, imperial Jue leaf 12g, Herba Polygoni cymosi 10g, Rabdosia rubescens 10g, Herba Inulae 6g, Pheretima 8g, Radix Glycyrrhizae 6g.
Clinical efficacy is summed up:
One, we are extensive in clinical practice for many years, treat routine patients up to a hundred, and curative effect is frequently good.Taboo: for Deficiency and coldness of spleen and stomach, the anorexia and loose stool person Radix Et Rhizoma Rhei of stopping using.
Two, diagnostic criteria: pulmonary fibrosis is many in the morbidity of 40-50 year, and the male is mainly in the women.Many with showing as of lung yin virtual loss when the state of an illness is lighter, show as that carrying out property is out of breath, dry cough, pulmonary's moist rales or crepitation.Imaging examination: be in early days ground-glass appearance, typical case's change diffusivity linear, nodositas, cloud wadding sample, netted shade, lung volume dwindle.
Three, administrated method: above all selection of crude drugs, mixing are added to the dense decoction of decocting into of water after soaking, every dose of 200ml, morning every day, late sub-service.
Four, efficacy evaluation:
Cure: clinical symptoms disappears fully, in 1 year more not repeatedly.
Take a turn for the better: clinical symptoms is improved.
Do not heal: clinical symptoms is without improving or increasing the weight of.
Five, therapeutic effect: treatment by Chinese herbs primary disease of the present invention, cure rate is more than 85% by statistics, and effective percentage is more than 95%.
Six, model case:
1, open XX, the female, 42 years old, in June, 2010 was medical, and patient main suit right side postoperative radiotherapy for breast cancer 1 month is coughed in the recent period, is breathed heavily with in a small amount sticky expectorant, and through in local commune hospital, giving Administration of roxithromycin, the prednisone sheet, reach cough mixture 1 week, poor effect.Have a medical check-up: the auscultation right lung has a large amount of dry rales.Imaging examination: right lung has cloud wadding sample, netted shade.The patient requires to take orally and 20 doses, external Chinese medicine of the present invention, and clinical symptoms disappears fully, and imaging examination is normal.Do not follow up a case by regular visits to and recur again after 1 year.
2, Song XX, female, 36 years old, peasant.Spring in 2011 is medical, patient main suit suffers from after the thymoma postoperation radiotherapy more than 20 days, cough, movable rear asthma appear, the sensation that has productive cough not go out, in my institute through having a medical check-up, CT examination is diagnosed as: the change of lung fibroid, through giving quiet of hormone, antibiotic 10 days, symptom take a favorable turn, and leaves hospital after going home to still have and feels suffocated, coughs.The patient requires to use respectively 20 doses of oral medicinal herb of the present invention and externals, and clinical symptoms disappears fully, after 1 year, does not follow up a case by regular visits to and recurs.
3. patient clump X, the female, 34 years old, the patient was medical in November, 2012, main suit's right side postoperative radiotherapy for breast cancer 1 month, occur coughing,, movable after asthma with in a small amount sticky expectorant, give Administration of roxithromycin through community hospital, cough mixture 5 days, poor effect.Have a medical check-up: the auscultation right lung has a large amount of dry rales.Imaging examination: the netted shade of left apex pulmonis section.The patient requires to take orally and 20 doses, external Chinese medicine of the present invention, and clinical symptoms disappears fully, and imaging examination is normal.Do not follow up a case by regular visits to and recur again after 1 year.

Claims (1)

1. the present invention relates to a kind of Chinese medicine preparation for the treatment of pulmonary fibrosis, it is characterized in that it is to be made by the medicine of following proportioning: Radix Glehniae 6~9g, Rhizoma Polygonati 6~9g, Rhizoma Dioscoreae Nipponicae 6~9g, Radix Platycodonis 6~9g, Cortex Syingae Amurensis 10~15g, Wingedtooth Laggera Herb 6~9g, imperial Jue leaf 9~12g, Herba Polygoni cymosi 10~12g, Rabdosia rubescens 10~15g, Herba Inulae 6~8g, Pheretima 6~8g, Radix Glycyrrhizae 6~9g.
CN201310466775.3A 2013-10-06 2013-10-06 Traditional Chinese medicine preparation for treating pulmonary fibrosis Pending CN103495025A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310466775.3A CN103495025A (en) 2013-10-06 2013-10-06 Traditional Chinese medicine preparation for treating pulmonary fibrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310466775.3A CN103495025A (en) 2013-10-06 2013-10-06 Traditional Chinese medicine preparation for treating pulmonary fibrosis

Publications (1)

Publication Number Publication Date
CN103495025A true CN103495025A (en) 2014-01-08

Family

ID=49860347

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310466775.3A Pending CN103495025A (en) 2013-10-06 2013-10-06 Traditional Chinese medicine preparation for treating pulmonary fibrosis

Country Status (1)

Country Link
CN (1) CN103495025A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019071658A1 (en) * 2017-10-09 2019-04-18 曾雁凌 Traditional chinese medicine composition treating pulmonary disease, preparation method and application
CN112402407A (en) * 2020-11-06 2021-02-26 北京恒润泰生医药科技有限公司 Rabdosia rubescens leaf water extract powder, preparation thereof, pulmonary fibrosis treatment effect and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088817A (en) * 1992-12-29 1994-07-06 淄博市淄川区第二制药厂 The Chinese medicine preparation of treatment tracheitis is coughed rather
CN1178110A (en) * 1996-09-28 1998-04-08 熊学贤 Medicine for lung cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088817A (en) * 1992-12-29 1994-07-06 淄博市淄川区第二制药厂 The Chinese medicine preparation of treatment tracheitis is coughed rather
CN1178110A (en) * 1996-09-28 1998-04-08 熊学贤 Medicine for lung cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张新等: "恶性肿瘤放射性肺炎的中医治疗", 《新中医》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019071658A1 (en) * 2017-10-09 2019-04-18 曾雁凌 Traditional chinese medicine composition treating pulmonary disease, preparation method and application
CN112402407A (en) * 2020-11-06 2021-02-26 北京恒润泰生医药科技有限公司 Rabdosia rubescens leaf water extract powder, preparation thereof, pulmonary fibrosis treatment effect and application

Similar Documents

Publication Publication Date Title
CN101972468B (en) Traditional Chinese medicine for treating bronchial asthma
CN102526674A (en) Medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven
CN103520413A (en) Chinese medicament for treating asthma
CN101549101B (en) Traditional Chinese medicine for treating pneumoconiosis and drug-tolerant pulmonary tuberculosis and preparation method thereof
CN103463566B (en) Traditional Chinese medicine composition for treating chronic bronchitis
CN101757516A (en) Prescription of traditional Chinese medicine for treating infantile allergic asthma
CN103495025A (en) Traditional Chinese medicine preparation for treating pulmonary fibrosis
CN103028047B (en) Chinese patent medicine for treating chronic pharyngolaryngitis
CN102210816A (en) Traditional Chinese medicine for treating radiation pneumonia
CN102188619A (en) Traditional Chinese medicine for treating radiation pneumonia
CN102631463B (en) Traditional Chinese medicine (TCM) for treating delayed encephalopathy after acute carbon monoxide poisoning
CN104721553A (en) Oral medicine for treating allergic rhinitis
CN103495130B (en) Traditional Chinese medicine composition for treating asthma
CN105056046A (en) Traditional Chinese medicine oral liquid for treating cold and cough and preparation method thereof
CN105617146A (en) Traditional Chinese medicine composition for preventing and treating infantile recurrent respiratory tract infection and preparation method thereof
CN105250966A (en) Foot bath medicine for treatment of yang deficiency and preparation method and application thereof
CN104998074A (en) Traditional Chinese medicine for treating gastropathy and preparation method thereof
CN104667129B (en) A kind of drug for treating rheumatic heart disease
CN104587369B (en) A kind of pharmaceutical composition for treating visceral dysfunction halitosis disease and preparation method thereof
CN103494924B (en) Chinese medicine composition for treating damp-heat stagnation acne
CN104189366A (en) Traditional Chinese medicine for treating pulmonary fibrosis
CN102641442B (en) Traditional Chinese medicine preparation for treating recurrent aphthae
CN104771673A (en) Traditional Chinese medicine for treating chronic bronchitis
CN105381260A (en) Traditional Chinese medicine for treating acquired immune deficiency syndrome and preparation method thereof
CN104491830A (en) Traditional Chinese medicine composition for preventing and controlling tuberculosis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140108